Scheheraza Sadegh-Nasseri

Medicine & Life Sciences

1. Peptides 100%
2. Major Histocompatibility Complex 89%
3. Antigen Presentation 80%
4. Histocompatibility Antigens Class II 70%
5. HLA-DR1 Antigen 70%
6. T-Lymphocytes 62%
7. Epitopes 61%
8. Immunodominant Epitopes 39%
9. Antigens 36%
10. T-Cell Antigen Receptor 29%
11. B-Lymphocytes 21%
12. invariant chain 20%
13. Helper-Inducer T-Lymphocytes 18%
14. Proteins 17%
15. Cathepsins 15%
16. Bispecific Antibodies 14%
17. Superantigens 12%
18. Antigen-Presenting Cells 12%
19. Muramidase 11%
20. Autoantigens 10%
21. Ligands 10%
22. HLA Antigens 10%
23. Kinetics 9%
24. HLA-DM antigens 9%
25. In Vitro Techniques 9%
26. Longevity 9%
27. HLA-DR Antigens 9%
28. tapasin 8%
29. Staphylococcal enterotoxin A 8%
30. Hate 8%
31. T-Lymphoid Precursor Cells 8%
32. Tolerogen 8%
33. Interleukin-2 8%
34. Cell Differentiation 8%
35. Protein-Arginine Deiminases 8%
36. Autoimmunity 7%
37. Autoimmune Diseases 7%
38. Burial 7%
39. PDZ Domains 7%
40. Aminopeptidases 6%
41. Thomsen-Friedenreich antibodies 6%
42. Chromosomes, Human, Pair 2 6%
43. Love 6%
44. Granzymes 6%
45. Histocompatibility Antigens 6%
46. Mentors 6%
47. Antigen Receptors 6%
48. Hydrogen Bonding 6%
49. Infections 6%
50. Structural Models 6%